Cash and Marketable Securities (Tables)

6 Months Ended

Jun. 30, 2023

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

A reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):

	June 30, 2023		June 30, 2022
Cash and cash equivalents	$	87,786	$	166,832
Restricted cash	584		204
Total cash, cash equivalents, and restricted cash at the end of the period	$	88,370	$	167,036

Schedule of Marketable Securities

The amortized cost, gross unrealized holding gains (losses), and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):

	June 30, 2023
	Amortized Cost		Unrealized Holding Gains (Losses)		Fair Value
Short-term marketable securities:
U.S. agency securities	$	101,666	$	1,672	$	103,338
Corporate debt securities	93,221		354		93,575
Total short-term marketable securities	194,887		2,026		196,913
Long-term marketable securities:
Corporate equity securities	5,100		(3,775)		1,325
Total long-term marketable securities	5,100		(3,775)		1,325
Total	$	199,987	$	(1,749)	$	198,238

	December 31, 2022
	Amortized Cost		Unrealized Holding Gains (Losses)		Fair Value
Short-term marketable securities:
U.S. agency securities	$	79,347	$	452	$	79,799
Corporate debt securities	123,821		(220)		123,601
Total short-term marketable securities	203,168		232		203,400
Long-term marketable securities:
Corporate equity securities	5,000		(2,924)		2,076
Total long-term marketable securities	5,000		(2,924)		2,076
Total	$	208,168	$	(2,692)	$	205,476

Contractual maturities of the marketable securities at each balance sheet date are as follows (in thousands):

	June 30, 2023		December 31, 2022
Within one year	$	194,887	$	203,168
After one year through five years	—		—
Total	$	194,887	$	203,168